Literature DB >> 8293679

Advances in cryosurgery during the past decade.

G F Graham1.   

Abstract

Many advances have been made in cryosurgery during the past decade. Important considerations are the high cure rate, good cosmetic result, convenience, and cost effectiveness. In an era of budget restraints with regard to medical care and in a time of concern with exposure to bloodborne pathogens, cryosurgery offers unique solutions. Cure rates for skin cancer in the area of 97 to 98 percent, for actinic keratosis, 98 percent, and for lentigo maligna, 96 percent, should encourage its use in more patients. The effectiveness in freezing lesions of leukoplakia, dermatofibroma, hemangioma, keloid, and lentigo adds to the versatility of the method. With the further development of ultrasound in measuring the depth of tumors prior to freezing and the availability of superior monitoring systems and perhaps helium cryosurgical units, cryosurgery could become the most widely used technique in dermatology. The development of a cryopeel for sundamaged skin provides an alternative treatment to the chemical peels in use today.

Entities:  

Mesh:

Year:  1993        PMID: 8293679

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

Review 1.  Cryosurgery for common skin lesions. Treatment in family physicians' offices.

Authors:  S J Wetmore
Journal:  Can Fam Physician       Date:  1999-04       Impact factor: 3.275

2.  Topical imiquimod therapy for actinic keratosis: is long-term clearance a realistic benefit?

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

Review 3.  [Cryosurgical treatment of actinic keratoses and evidence-based review].

Authors:  C C Zouboulis; H Röhrs
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

4.  Clinical practice trends in cryosurgery: a retrospective study of cutaneous lesions.

Authors:  Fatma Sule Afsar; Ceren Dagar Erkan; Semsettin Karaca
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.